Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chenying Shu

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|February 20, 2024
Tea intake and lung diseases: a Mendelian randomization studyZhengyan Wu, Min Jiao, Chenying Shu, et al.
Frontiers in Pharmacology|June 11, 2025
Isoliensinine exerts antitumor effects in lung adenocarcinoma by inhibiting APEX1-driven ROS productionCheng Chen, Chenying Shu, Dan Shen, et al.
Materials Today. Bio|September 2, 2025
Immuno-protective cationic ginsenoside Rb1 vesicles for macrophage-mediated targeted therapy of inflammatory diseasesJiawen Luo, Huizhen Fan, Chenying Shu, et al.
Cell Communication and Signaling : CCS|June 6, 2024
Integrin αVβ1-activated PYK2 promotes the progression of non-small-cell lung cancer via the STAT3-VGF axisZhengyan Wu, Min Jiao, Chenying Shu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 26, 2024
Isotoosendanin exerts anti-tumor effects in NSCLC by enhancing the stability of SHP-2 and inhibiting the JAK/STAT3 pathwayChenying Shu, Yuling Chen, Zhengyan Wu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 7, 2025
Liensinine overcomes EGFR-TKI resistance in lung adenocarcinoma through DRP1-mediated autophagyYuling Chen, Chenying Shu, Zhaowei Yan, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|October 15, 2024
Diosmin reduces the stability of Snail and Cyclin D1 by targeting FAK to inhibit NSCLC progressionChenkang Ma, Mengxia Dan, Ying Wang, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|February 20, 2024
Tea intake and lung diseases: a Mendelian randomization studyZhengyan Wu, Min Jiao, Chenying Shu, et al.
Frontiers in Pharmacology|June 11, 2025
Isoliensinine exerts antitumor effects in lung adenocarcinoma by inhibiting APEX1-driven ROS productionCheng Chen, Chenying Shu, Dan Shen, et al.
Materials Today. Bio|September 2, 2025
Immuno-protective cationic ginsenoside Rb1 vesicles for macrophage-mediated targeted therapy of inflammatory diseasesJiawen Luo, Huizhen Fan, Chenying Shu, et al.
Cell Communication and Signaling : CCS|June 6, 2024
Integrin αVβ1-activated PYK2 promotes the progression of non-small-cell lung cancer via the STAT3-VGF axisZhengyan Wu, Min Jiao, Chenying Shu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 26, 2024
Isotoosendanin exerts anti-tumor effects in NSCLC by enhancing the stability of SHP-2 and inhibiting the JAK/STAT3 pathwayChenying Shu, Yuling Chen, Zhengyan Wu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 7, 2025
Liensinine overcomes EGFR-TKI resistance in lung adenocarcinoma through DRP1-mediated autophagyYuling Chen, Chenying Shu, Zhaowei Yan, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|October 15, 2024
Diosmin reduces the stability of Snail and Cyclin D1 by targeting FAK to inhibit NSCLC progressionChenkang Ma, Mengxia Dan, Ying Wang, et al.
Pageof 1